交易中 09-24 10:51:33 美东时间
-0.300
-0.24%
今日重点评级关注:Citizens:上调Quince Therapeutics评级至"跑赢大市",目标价77美元;康托·菲茨杰拉德:维持塞德斯医疗"超配"评级,目标价从61美元升至72美元
09-23 15:30
RBC Capital analyst Brian Abrahams reiterates Incyte (NASDAQ:INCY) with a Sector Perform and maintains $109 price target.
09-22 21:24
Vicor电子暴升11.21%;Grab Holdings大升5.50%;游戏驿站上升2.90%
09-22 16:11
Vicor电子暴升11.43%;Grab Holdings大升6.53%;游戏驿站上升3.69%
09-22 15:01
SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte Biosciences...
09-21 04:00
Insiders have been trading these 5 stocks: (($AFL)), (($CME)), (($INCY)), (($BO...
09-19 21:01
On CNBC’s “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, picked The Charles Schwab Corporation (NYSE:SCHW). Compass Point analyst Ed Engel, on Aug. 3, initiated coverage on Charles Schwab with a Buy rating and announced a p...
09-17 19:31
布鲁克菲尔德资产管理上升3.34%;阿里拉姆制药上升2.54%;Sunbelt Rentals Holdings Inc小升1.93%
09-12 06:10
Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.25% on an annualized basis producing an average annual return of 17.44%. Currently, Incyte has a market capitalization of $24.69 billion. Buying $1000 In INCY: If an investor had bought $1000 of INCY stock 20 years ago, it ...
09-11 23:30
An announcement from Incyte ( ($INCY) ) is now available. Incyte Corporation sa...
09-01 04:47